Uploaded by zivapogacnik05

Opioid Addiction PPT

advertisement
HOW CAN WE
GUARANTEE THAT
YOU WON'T BE A
PART OF THE 16
MILLION?
OPIOID
ADDICTION
CONTENT
01
02
BR IEF HISTOR Y
03
04
05
O VER DO SES
EFFECTS ON THE HUMAN BODY
P R EVENT IO N
TR EATMENT
HISTORY
• Discovery in Ancient Egyptian texts
• Derivate of the poppy flower
• 19th century - morphine
• Heroin, oxycodone, fentanyl,
hydrocodone...
• Propaganda in the 1980s - crisis
• Opioids vs opiates
EFFECTS ON THE HUMAN BODY
• endorphins vs
opioids
Receptors
• dopamine release opioid high
• noradrenaline
• larger doses - compensating
• more noradrenaline
receptors
Tolerance
• dependence
• elimination of extra
Abrupt
receptors
• violent
withdrawals
Sobriety
• high risk of
overdose
OVERDOSES
How?
• Use after withdr awal - risky
• Standar d dose before - now lethal
• Overprescr ibt ions - tight regulations
• Early cases vs current cases
• Illicit vs legal - lacing with fentanyl
• 600,000 deaths related this year - 150,000
directly
• Prevention? Treatment?
Statistics
PREVENTION
• binds to
receptors
• reverses
overdose
• expensive
NALOXONE
• tighter
regulations
• high-risk
individuals
REGULATIONS
TREATMENT
• expensive yet
effective
• complete
detoxificat ion
• employment loss
MAINTENANCE
PROGRAMS
burprenophine
methadone
not psychoactive
scarce - black
market
• special waiver
•
•
•
•
DRUGS
•
•
•
•
long waiting lists
medications
health services
psychotherapy
INPAINTENT
PROGRAMS
01 587 49
76
SOURCES
• Hser, Yih-Ing, et al. "Long-term course of opioid addiction."
Harvard review of psychiatry 23.2 (2015): 76-89
• Azadfard, Mohammadreza, Martin R. Huecker, and James M.
Leaming. "Opioid addiction." StatPearls [Internet].
StatPearls Publishing, 2023.
• Crist, Richard C., Benjamin C. Reiner, and Wade H. Berrettini. "A
review of opioid addiction genetics." Current opinion in
psychology 27 (2019): 31-35.
• Boddiger, David. "Fentanyl-laced street drugs “kill
hundreds”." The Lancet 368.9535 (2006): 569-570.
• Fodale, Vincenzo, et al. "Killer fentanyl: is the fear justified?."
Expert Opinion on Drug Safety 7.3 (2008): 213-217.
THANK YOU
FOR
LISTENING
Živa Pogačnik
Download